tirzepatide compound fda shortage says years-long is resolved, will give limited leeway to compounders Compounders protest as FDA removes

Although effective and safe treatments for obesity exist, weight loss medications are rarely prescribed for adults with obesity

Weight Watchers stopped offering compounded semaglutide on May 21, 2025, after the FDA issued a warning letter to all compounding pharmacies stating that compounded semaglutide should not be dispensed and distributed unless medically necessary

However, it is essential to understand how supplements can interact with these medications

Keep in mind that humans are not rats

Kobayati A, Haidar A, Tsoukas MA (2022) Glucagon-like peptide-1 receptor agonists as adjunctive treatment for type 1 diabetes: renewed opportunities through tailored approaches

Aim for half your body weight in ounces of water daily